LLY

887.18

+1.05%↑

JNJ

242.06

+0.74%↑

ABBV

212.74

+1.46%↑

NVS

150.53

+1.54%↑

MRK

118.03

-1.38%↓

LLY

887.18

+1.05%↑

JNJ

242.06

+0.74%↑

ABBV

212.74

+1.46%↑

NVS

150.53

+1.54%↑

MRK

118.03

-1.38%↓

LLY

887.18

+1.05%↑

JNJ

242.06

+0.74%↑

ABBV

212.74

+1.46%↑

NVS

150.53

+1.54%↑

MRK

118.03

-1.38%↓

LLY

887.18

+1.05%↑

JNJ

242.06

+0.74%↑

ABBV

212.74

+1.46%↑

NVS

150.53

+1.54%↑

MRK

118.03

-1.38%↓

LLY

887.18

+1.05%↑

JNJ

242.06

+0.74%↑

ABBV

212.74

+1.46%↑

NVS

150.53

+1.54%↑

MRK

118.03

-1.38%↓

Search

Quanterix Corp

Aperta

SettoreSettore sanitario

3.39 -5.04

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

3.35

Massimo

3.57

Metriche Chiave

By Trading Economics

Entrata

10M

-23M

Vendite

3.7M

44M

Margine di Profitto

-52.712

Dipendenti

450

EBITDA

15M

-17M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+109.5% upside

Dividendi

By Dow Jones

Utili prossimi

11 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-111M

185M

Apertura precedente

8.43

Chiusura precedente

3.39

Notizie sul Sentiment di mercato

By Acuity

50%

50%

153 / 349 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Neutral Evidence

Quanterix Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 mar 2026, 17:33 UTC

Principali Notizie su Eventi

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27 mar 2026, 17:00 UTC

Principali Notizie su Eventi

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27 mar 2026, 16:03 UTC

Principali Notizie su Eventi

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29 mar 2026, 23:47 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Gold Falls Amid Rising Inflation Fears -- Market Talk

29 mar 2026, 23:46 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29 mar 2026, 23:35 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29 mar 2026, 23:23 UTC

Discorsi di Mercato

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29 mar 2026, 22:34 UTC

Discorsi di Mercato

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29 mar 2026, 22:09 UTC

Discorsi di Mercato

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29 mar 2026, 21:06 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29 mar 2026, 21:03 UTC

Discorsi di Mercato

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29 mar 2026, 21:01 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29 mar 2026, 09:30 UTC

Acquisizioni, Fusioni, Takeovers

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28 mar 2026, 08:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

27 mar 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

27 mar 2026, 19:16 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27 mar 2026, 19:07 UTC

Discorsi di Mercato

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27 mar 2026, 19:04 UTC

Discorsi di Mercato

Gold Rises But Can't Finish the Week Positive -- Market Talk

27 mar 2026, 19:03 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 19:02 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27 mar 2026, 18:12 UTC

Discorsi di Mercato

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27 mar 2026, 17:36 UTC

Principali Notizie su Eventi

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27 mar 2026, 17:34 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27 mar 2026, 17:29 UTC

Discorsi di Mercato

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27 mar 2026, 16:38 UTC

Discorsi di Mercato

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27 mar 2026, 16:32 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27 mar 2026, 16:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

27 mar 2026, 15:43 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27 mar 2026, 15:25 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 15:25 UTC

Discorsi di Mercato

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Confronto tra pari

Modifica del prezzo

Quanterix Corp Previsione

Obiettivo di Prezzo

By TipRanks

109.5% in crescita

Previsioni per 12 mesi

Media 7.5 USD  109.5%

Alto 8 USD

Basso 7 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Quanterix Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

2 ratings

0

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

5.34 / 6.015Supporto e resistenza

A breve termine

Neutral Evidence

A termine intermedio

Bullish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

153 / 349 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat